Stay updated on Pembrolizumab for Intermediate Risk NMIBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Intermediate Risk NMIBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Intermediate Risk NMIBC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page revision label was updated to v3.6.3, and older revision text along with links such as 'Bladder cancer' and 'MedlinePlus Genetics' were removed.
    Difference
    0.2%
    Check dated 2026-07-06T15:52:11.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2, replacing the previous v3.6.0. This reflects a minor version update to the page template.
    Difference
    0.1%
    Check dated 2026-06-29T08:42:55.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    Recruitment status shows no longer looking for participants. New user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) have been added, the Intervention/Treatment header formatting updated (from 'Intervention / Treatment' to 'Intervention/Treatment'), and the revision tag updated to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-15T06:00:38.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.5.5, replacing the previous Revision: v3.5.4. This indicates a small software update to the site.
    Difference
    0.1%
    Check dated 2026-06-08T03:48:48.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page no longer displays links or sections for bladder cancer, related topics, and MedlinePlus Genetics, reducing navigational references to these topics on the study page.
    Difference
    0.2%
    Check dated 2026-06-01T01:07:38.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    New navigation items were added to the page: 'Bladder cancer' and a 'related topics' section featuring 'MedlinePlus Genetics', providing additional context and links to related resources.
    Difference
    0.2%
    Check dated 2026-05-24T13:24:30.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Intermediate Risk NMIBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Intermediate Risk NMIBC Clinical Trial page.